Observational study explores the effect of financial incentives on smoking cessation treatment use, suggesting barriers remain.
INTRODUCTION: Healthcare professionals are recommended to deliver smoking cessation support (SCS) to smokers. However, the effectiveness of provider-level financial incentives on smoker's behaviors, including the use of smoking cessation treatment (SCT), has been controversial. The aim of this observational study was to explore the association of a provider-level incentive to deliver a general lifestyle intervention, including SCS, with the smoker's use of SCT, and describe the current state of and barriers to delivering SCS at health check-up settings. METHODS: This observational study in a health check-up setting consisted of: 1) a retrospective, quasi-experimental study through secondary use of an administrative claims database between 2018 and 2020; and 2) a cross-sectional questionnaire survey in 2023. Change in the proportion of SCT users pre- and post-introduction of the incentive was analyzed using a claims database, employing a difference-in-difference (DID) approach using adjusted linear regression. To describe SCS at health check-up settings, a cross-sectional survey was sent to 26 health check-up centers that had received the incentives which requested a response from a healthcare professional at each center. Responses were presented as descriptive statistics. RESULTS: DID analysis using data for 126137 smokers revealed no significant change in the proportion of SCT users following introduction of the provider-level incentive (DID= -0.15; 95% CI: -1.09-0.80 per 1000 smokers, p=0.759). The survey, which received responses from 24 health check-up centers, showed that only 27% of these centers provided smokers with contact information for SCT services. Furthermore, 71% and 67% of centers cited a lack of resources and self-efficacy, respectively, as perceived barriers to the delivery of SCS. CONCLUSIONS: The provider-level incentive to deliver the general lifestyle intervention was not associated with SCT use in health check-up settings. Increasing SCT use may require strategies aimed at overcoming barriers to the delivery of SCS.
No takes yet. Share an insight, caveat, or question.
Yuwaki et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: